We are live on ! Find out more
Royal Bank of Canada

Royal Bank of Canada Portfolio holdings

AUM $672B
1-Year Est. Return 33.48%
 

Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.

This Fund
S&P 500
This Quarter Est. Return
+5.73%
1 Year Est. Return
+33.48%
3 Year Est. Return
+94.84%
5 Year Est. Return
+111.06%
10 Year Est. Return
+380.55%
AUM
$381B
AUM Growth
+$27.2B
Cap. Flow
+$10.3B
Cap. Flow %
2.7%
Top 10 Hldgs %
19.31%
Holding
8,037
New
675
Increased
3,796
Reduced
2,511
Closed
409

Sector Composition

Rank Sector Weight
1 Financials 18.63%
2 Technology 14.62%
3 Industrials 7.95%
4 Healthcare 7.93%
5 Energy 7.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RNLX
5601
DELISTED
Renalytix plc American Depositary Shares
RNLX
$58K ﹤0.01%
+20,000
New +$45.3K
FNCB
5602
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
$58K ﹤0.01%
9,851
+7,189
+270% +$43.2K
CZWI icon
5603
Citizens Community Bancorp
CZWI
$203M
$57K ﹤0.01%
6,382
+82
+1% +$754
DYN icon
5604
Dyne Therapeutics
DYN
$4.8B
$57K ﹤0.01%
5,078
+2,140
+73% +$25.2K
ENTA icon
5605
Enanta Pharmaceuticals
ENTA
$383M
$57K ﹤0.01%
2,665
+1,085
+69% +$32K
KRMD icon
5606
KORU Medical Systems
KRMD
$157M
$57K ﹤0.01%
16,611
+10,570
+175% +$41.5K
LU icon
5607
Lufax Holding
LU
$1.3B
$57K ﹤0.01%
9,916
-417
-4% -$2.76K
LXFR icon
5608
Luxfer Holdings
LXFR
$457M
$57K ﹤0.01%
4,001
+2,063
+106% +$31.6K
PTVE
5609
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$57K ﹤0.01%
7,513
-3,445
-31% -$26.3K
INSI
5610
DELISTED
Insight Select Income Fund
INSI
$57K ﹤0.01%
3,667
MDNA
5611
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$57K ﹤0.01%
118,760
-4,368
-4% -$2.7K
ALX
5612
Alexander's
ALX
$1.38B
$56K ﹤0.01%
308
+19
+7% +$3.42K
BIVI icon
5613
BioVie
BIVI
$10.6M
$56K ﹤0.01%
130
+125
+2,500% +$84.2K
DISV icon
5614
Dimensional International Small Cap Value ETF
DISV
$5.19B
$56K ﹤0.01%
2,359
-6,098
-72% -$146K
GEVO icon
5615
Gevo
GEVO
$418M
$56K ﹤0.01%
37,396
+24,978
+201% +$32.3K
IBBQ icon
5616
Invesco NASDAQ Biotechnology ETF
IBBQ
$80.1M
$56K ﹤0.01%
2,728
-596
-18% -$12.5K
JHI
5617
John Hancock Investors Trust
JHI
$118M
$56K ﹤0.01%
4,463
SSO icon
5618
ProShares Ultra S&P500
SSO
$8.47B
$56K ﹤0.01%
1,920
+80
+4% +$2.09K
TBI
5619
Trueblue
TBI
$311M
$56K ﹤0.01%
3,173
+1,373
+76% +$23.3K
AVPT icon
5620
AvePoint
AVPT
$2.85B
$55K ﹤0.01%
9,529
-1,021
-10% -$5.38K
AZUL
5621
DELISTED
Azul
AZUL
$55K ﹤0.01%
4,035
-540
-12% -$4.91K
FORR icon
5622
Forrester Research
FORR
$217M
$55K ﹤0.01%
1,919
+749
+64% +$22.3K
OSW icon
5623
OneSpaWorld
OSW
$2.73B
$55K ﹤0.01%
4,568
-305
-6% -$3.53K
SNPD icon
5624
Xtrackers S&P ESG Dividend Aristocrats ETF
SNPD
$3.12M
$55K ﹤0.01%
2,202
-1,140
-34% -$28.2K
TSI
5625
TCW Strategic Income Fund
TSI
$214M
$55K ﹤0.01%
11,926
-3,500
-23% -$16.4K

Similar funds

Royal Bank of Canada's Q2 2023 Portfolio in Review

As of Q2 2023, Royal Bank of Canada held 8,037 positions worth $381B, up 7.7% from $354B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Royal Bank of Canada's Q2 2023 filing shows 675 new, 3,796 increased, 2,511 reduced and 409 closed positions. Its largest new stake was ATS Corp: 3,088,815 shares worth $142M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $815M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.

  • Royal Bank of Canada's largest Q2 2023 buy was ATS Corp: 3,088,815 shares worth $142M.
  • Royal Bank of Canada added most to Thermo Fisher Scientific in Q2 2023, an estimated $987M increase.
  • Royal Bank of Canada's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $815M.
  • Royal Bank of Canada fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $150M.
  • Royal Bank of Canada's ten largest holdings make up 19% of its $381B portfolio in Q2 2023.
  • Royal Bank of Canada opened 675 new positions and closed 409 in Q2 2023.
  • Royal Bank of Canada's portfolio value rose 7.7% quarter-over-quarter to $381B.

Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.